// App-Quantinova.ai

13519 : Signaling via PI3K? and PI3K? and Increased Glucose Oxidation Contribute to the Marked Protection Against Ischemia/Reperfusion Injury in PI3K?DN Hearts

Researchers

Presenter

  • Wang Wang

Principal Investigators

  • Petra C Kienesberger

  • Grant Masson

  • Jason Dyck

  • Gavin Y. Oudit

Medical Centers

  • Univ. of Alberta, Edmonton, Alberta, Canada.

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Ischemia-reperfusion injury

Biomarkers

  • AMP-activated protein kinase

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Drug/Treatment

  • Phosphatidylinositol

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved